108 related articles for article (PubMed ID: 16469711)
1. [Knockdown of PLK1 mRNA by special siRNA].
Chen GX; Dong QH; Zhang JW; Fu FF; Xu ZF; Liang QY; Zheng S; Ding JY
Yi Chuan; 2006 Jan; 28(1):21-5. PubMed ID: 16469711
[TBL] [Abstract][Full Text] [Related]
2. [Influence of silencing Polo-like kinase 1 on migration and invasion of colorectal cancer cells].
Han DP; Cui JT; Lu AG; Chen XH; Feng B; Zong YP; Qu S; Cao QF; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):61-4. PubMed ID: 21271384
[TBL] [Abstract][Full Text] [Related]
3. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
[TBL] [Abstract][Full Text] [Related]
4. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
Reagan-Shaw S; Ahmad N
FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
[TBL] [Abstract][Full Text] [Related]
5. [Mitosis arrest caused by inhibition of PLK1 expression in gastric cancer MKN45 cells].
Lan B; Liu BY; Chen XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):164-8. PubMed ID: 16875597
[TBL] [Abstract][Full Text] [Related]
6. [Effect of PLK1 gene silence on cell cycle, proliferation and drug resistance in K562/A02 cells].
Liu L; Zhang M; Zou P; Tian L; Liu F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):241-6. PubMed ID: 16638189
[TBL] [Abstract][Full Text] [Related]
7. [Study of growth inhibition of gastric cancer cells by sRNA targeting polo like kinase 1 in vitro and vivo].
Lan B; Liu BY; Cheng XH; Qu Y; Zhang XQ; Cai Q; Dai QB; Zhu ZG
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(1):40-4. PubMed ID: 16620646
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of polo like kinase gene expression induces apoptosis in gastric cancer cells].
Lan B; Liu BY; Cheng XH; Qu Y; Zhang XQ; Cai Q; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):62-6. PubMed ID: 16437376
[TBL] [Abstract][Full Text] [Related]
9. [Effect of antisense RNA targeting Polo-like kinase 1 on cell cycle of lung cancer cell line A549].
Zhou Q; Bai M; Su Y
Ai Zheng; 2005 Feb; 24(2):149-54. PubMed ID: 15694023
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of Polo-like kinase 1 (PLK1) expression in human malignant glioma.
Cheng MW; Wang BC; Weng ZQ; Zhu XW
Acta Histochem; 2012 Sep; 114(5):503-9. PubMed ID: 22000864
[TBL] [Abstract][Full Text] [Related]
11. [Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin].
Liu L; Zhang M; Zou P; Tian L; Liu F
Ai Zheng; 2006 Apr; 25(4):404-8. PubMed ID: 16613670
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of polo-like kinase 1 promotes hyperthermia sensitivity via inactivation of heat shock transcription factor 1 in human retinoblastoma cells.
Yunoki T; Tabuchi Y; Hayashi A; Kondo T
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8353-63. PubMed ID: 24366665
[TBL] [Abstract][Full Text] [Related]
13. Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells.
Gomes-da-Silva LC; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):356-64. PubMed ID: 23659854
[TBL] [Abstract][Full Text] [Related]
14. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
Bu Y; Yang Z; Li Q; Song F
Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
[TBL] [Abstract][Full Text] [Related]
15. RNAi prodrugs targeting Plk1 induce specific gene silencing in primary cells from pediatric T-acute lymphoblastic leukemia patients.
Kolosenko I; Edsbäcker E; Björklund AC; Hamil AS; Goroshchuk O; Grandér D; Dowdy SF; Palm-Apergi C
J Control Release; 2017 Sep; 261():199-206. PubMed ID: 28684168
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.
McCarroll JA; Dwarte T; Baigude H; Dang J; Yang L; Erlich RB; Kimpton K; Teo J; Sagnella SM; Akerfeldt MC; Liu J; Phillips PA; Rana TM; Kavallaris M
Oncotarget; 2015 May; 6(14):12020-34. PubMed ID: 25557168
[TBL] [Abstract][Full Text] [Related]
17. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
[TBL] [Abstract][Full Text] [Related]
18. [Growth inhibition of MG-63 cells by cyclin A2 gene-specific small interfering RNA].
Liu Y; Fan SW; Ding JY; Zhao X; Shen WL
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(9):627-33. PubMed ID: 17550735
[TBL] [Abstract][Full Text] [Related]
19. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells.
Spänkuch-Schmitt B; Bereiter-Hahn J; Kaufmann M; Strebhardt K
J Natl Cancer Inst; 2002 Dec; 94(24):1863-77. PubMed ID: 12488480
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Polo-like kinase 1 induces cellular senescence in human primary cells through a p53-dependent pathway.
Kim HJ; Cho JH; Kim JR
J Gerontol A Biol Sci Med Sci; 2013 Oct; 68(10):1145-56. PubMed ID: 23525475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
